Home › Funds › Bellevue Group AG › SRRK
Bellevue Group AG position in SRRK
SCHOLAR ROCK HLDG CORP · Health Care
Bellevue Group AG reported holding 2,449,547 shares of SRRK (SCHOLAR ROCK HLDG CORP) in its Q2 2026 13F filing — a position valued at US$134.7M, representing 2.83% of its reported portfolio and ranking #8 among its reported holdings. Bellevue Group AG has disclosed SRRK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Bellevue Group AG's SRRK position evolved
Bellevue Group AG first disclosed a stake in SRRK in Q3 2023 at 2,137,925 shares (US$15.2M). The position peaked in Q4 2025 at 4,056,592 shares, worth US$178.7M. Across 12 filings, Bellevue Group AG increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 2,449,547 shares valued at US$134.7M — a reduction of -1,135,026 shares quarter over quarter.. Notable position changes include a 25% increase in Q4 2025 (shares rose 12% over the following quarter), a 32% trim in Q2 2026 (shares fell 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.14M | $15.18M | New |
| Q4 2023 | 2.17M | $40.78M | Add |
| Q1 2024 | 2.17M | $38.45M | Hold |
| Q2 2024 | 2.17M | $18.04M | Hold |
| Q3 2024 | 2.16M | $17.31M | Hold |
| Q4 2024 | 2.51M | $108.51M | Add |
| Q1 2025 | 2.51M | $80.60M | Hold |
| Q2 2025 | 2.95M | $104.39M | Add |
| Q3 2025 | 3.24M | $120.83M | Add |
| Q4 2025 | 4.06M | $178.69M | Add |
| Q1 2026 | 3.58M | $176.22M | Reduce |
| Q2 2026 | 2.45M | $134.73M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SRRK and 13F data
SRRK (SCHOLAR ROCK HLDG CORP) is a Health Care company. 53 other funds we track also report a position in SRRK — the largest reported positions include Siren, L.L.C. (US$526.6M), Samsara BioCapital, LLC (US$379.4M), Orbis Allan Gray Ltd (US$326.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SRRK
- Siren, L.L.C. 9.58M sh · $526.63M · Q2 2026
- Samsara BioCapital, LLC 6.90M sh · $379.37M · Q2 2026
- Orbis Allan Gray Ltd 5.93M sh · $326.34M · Q2 2026
- Redmile Group, LLC 4.31M sh · $237.11M · Q2 2026
- Hood River Capital Management LLC 2.22M sh · $122.36M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 2.21M sh · $121.31M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 2.11M sh · $116.13M · Q2 2026
- Integral Health Asset Management, LLC 750.00K sh · $41.25M · Q2 2026
- Rock Springs Capital Management LP 715.45K sh · $39.35M · Q2 2026
- Casdin Capital 665.00K sh · $36.58M · Q2 2026
- Eagle Health Investments LP 555.27K sh · $30.54M · Q2 2026
More on Bellevue Group AG
FAQ
How long has Bellevue Group AG held SRRK?
Bellevue Group AG has disclosed SRRK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Bellevue Group AG's current position in SRRK?
As of Q2 2026, Bellevue Group AG holds 2.45M shares of SRRK (SCHOLAR ROCK HLDG CORP), valued at $134.73M, representing 2.83% of its reported portfolio and ranking #8.
Has Bellevue Group AG been buying or selling SRRK?
In the latest 13F filing (Q2 2026), Bellevue Group AG reduced its position in SRRK. The position peaked in Q4 2025 at 4.06M shares.
Which other funds hold SRRK?
Other major institutional holders of SRRK include Siren, L.L.C., Samsara BioCapital, LLC, Orbis Allan Gray Ltd, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.